Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-05-06 | Amended | $170,574,224 | $170,574,224 | Equity Only | 06b | SEC link |
| 2024-03-21 | New | $0 | $0 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Patrick Barry | Executive |
| Mark Bradley | Director, Executive |
| Blaise Coleman | Director, Executive |
| Paul Efron | Director |
| Paul Herendeen | Director |
| Scott Hirsch | Director |
| Sophia Langlois | Director |
| Matthew Maletta | Executive |
| Brian Morrissey | Executive |
| Andy Pasternak | Director |
| Frank Raciti | Executive |
| Deanna Voss | Executive |
| Marc Yoskowitz | Director |